These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8597462)

  • 1. DHEAS as an effective vaccine adjuvant in elderly humans. Proof-of-principle studies.
    Araneo B; Dowell T; Woods ML; Daynes R; Judd M; Evans T
    Ann N Y Acad Sci; 1995 Dec; 774():232-48. PubMed ID: 8597462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of oral dehydroepiandrosterone sulfate as an adjuvant in tetanus and influenza vaccination of the elderly.
    Evans TG; Judd ME; Dowell T; Poe S; Daynes RA; Araneo BA
    Vaccine; 1996 Nov; 14(16):1531-7. PubMed ID: 9014295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of DHEAS on influenza vaccination in aging adults.
    Degelau J; Guay D; Hallgren H
    J Am Geriatr Soc; 1997 Jun; 45(6):747-51. PubMed ID: 9180672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of sequential annual vaccination and of DHEA administration on the efficacy of the immune response to influenza vaccine in the elderly.
    Ben-Yehuda A; Danenberg HD; Zakay-Rones Z; Gross DJ; Friedman G
    Mech Ageing Dev; 1998 May; 102(2-3):299-306. PubMed ID: 9720660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist as Adjuvant.
    Beljanski V; Chiang C; Kirchenbaum GA; Olagnier D; Bloom CE; Wong T; Haddad EK; Trautmann L; Ross TM; Hiscott J
    J Virol; 2015 Oct; 89(20):10612-24. PubMed ID: 26269188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duration of immunity induced by an equine influenza and tetanus combination vaccine formulation adjuvanted with ISCOM-Matrix.
    Heldens JG; Pouwels HG; Derks CG; Van de Zande SM; Hoeijmakers MJ
    Vaccine; 2010 Oct; 28(43):6989-96. PubMed ID: 20728523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination of adults 65 years of age and older with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Boostrix(®)): results of two randomized trials.
    Weston WM; Friedland LR; Wu X; Howe B
    Vaccine; 2012 Feb; 30(9):1721-8. PubMed ID: 22212127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dehydroepiandrosterone sulphate enhances IgG and Interferon-gamma production during immunization to tuberculosis in young but not aged mice.
    Ribeiro F; Lopes RP; Nunes CP; Maito F; Bonorino C; Bauer ME
    Biogerontology; 2007 Apr; 8(2):209-20. PubMed ID: 17082909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of belimumab on vaccine antigen antibodies to influenza, pneumococcal, and tetanus vaccines in patients with systemic lupus erythematosus in the BLISS-76 trial.
    Chatham WW; Wallace DJ; Stohl W; Latinis KM; Manzi S; McCune WJ; Tegzová D; McKay JD; Avila-Armengol HE; Utset TO; Zhong ZJ; Hough DR; Freimuth WW; Migone TS;
    J Rheumatol; 2012 Aug; 39(8):1632-40. PubMed ID: 22707609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of tetanus toxoid as a differentiating infected from vaccinated animals (DIVA) strategy for sero-surveillance of avian influenza virus vaccination in poultry.
    James CM; Foong YY; Mansfield JP; Fenwick SG; Ellis TM
    Vaccine; 2007 Aug; 25(31):5892-901. PubMed ID: 17583393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of avian influenza A/Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial.
    Belshe RB; Frey SE; Graham IL; Anderson EL; Jackson LA; Spearman P; Edupuganti S; Mulligan MJ; Rouphael N; Winokur P; Dolor RJ; Woods CW; Walter EB; Chen WH; Turley C; Edwards KM; Creech CB; Hill H; Bellamy AR;
    JAMA; 2014 Oct; 312(14):1420-8. PubMed ID: 25291578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of a numerically additive combined vaccine against tetanus and smallpox].
    Mayr A; Baljer G; Wagner C; Sailer J
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Apr; 259(2):206-18. PubMed ID: 2990123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to influenza vaccine in people with non-protective HI antibody titers.
    Baldo V; Baldovin T; Floreani A; Minuzzo M; Trivello R
    Eur J Epidemiol; 2006; 21(11):843-5. PubMed ID: 17082899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125, STF2.HA1 SI).
    Taylor DN; Treanor JJ; Strout C; Johnson C; Fitzgerald T; Kavita U; Ozer K; Tussey L; Shaw A
    Vaccine; 2011 Jul; 29(31):4897-902. PubMed ID: 21596084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.
    de Haan A; Haijema BJ; Voorn P; Meijerhof T; van Roosmalen ML; Leenhouts K
    Vaccine; 2012 Jul; 30(32):4884-91. PubMed ID: 22537989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dehydroepiandrosterone treatment is not beneficial to the immune response to influenza in elderly subjects.
    Danenberg HD; Ben-Yehuda A; Zakay-Rones Z; Gross DJ; Friedman G
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2911-4. PubMed ID: 9284718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Immunogenicity of the Tetanus Toxoid and Recombinant Tetanus Vaccines in Mice, Rats, and Cynomolgus Monkeys.
    Yu R; Fang T; Liu S; Song X; Yu C; Li J; Fu L; Hou L; Xu J; Chen W
    Toxins (Basel); 2016 Jun; 8(7):. PubMed ID: 27348002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of apoptosis-associated speck-like protein containing a caspase recruitment domain on vaccine efficacy: Overcoming the effects of its deficiency with aluminum hydroxide adjuvant.
    Lee DK; Lee EY; Kim RH; Kwak HW; Kim JY; Kim H; Kang KW; Lee SM; Park JH; Chang J; Nam JH
    Microbiol Immunol; 2018 Mar; 62(3):176-186. PubMed ID: 29315762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved immunogenicity of tetanus toxoid by Brucella abortus S19 LPS adjuvant.
    Mohammadi M; Kianmehr Z; Kaboudanian Ardestani S; Gharegozlou B
    Iran J Immunol; 2014 Sep; 11(3):189-99. PubMed ID: 25266004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of the safety and immunogenicity of a five-component acellular pertussis, diphtheria, and tetanus toxoid vaccine (DTaP) when combined with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine (PRP-T) in Taiwanese infants.
    Lee CY; Thipphawong J; Huang LM; Lee PI; Chiu HH; Lin W; Debois H; Harrison D; Xie F; Barreto L
    Pediatrics; 1999 Jan; 103(1):25-30. PubMed ID: 9917435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.